Provided by Tiger Trade Technology Pte. Ltd.

ORTHOCELL LTD

0.800
-0.035-4.19%
Volume:113.27K
Turnover:90.37K
Market Cap:216.87M
PE:-15.34
High:0.820
Open:0.820
Low:0.790
Close:0.835
52wk High:1.600
52wk Low:0.700
Shares:271.09M
Float Shares:194.08M
Volume Ratio:0.40
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.052
EPS(LYR):-0.038
ROE:-41.06%
ROA:-20.97%
PB:5.27
PE(LYR):-20.85

Loading ...

Company Profile

Company Name:
ORTHOCELL LTD
Exchange:
ASX
Establishment Date:
2006
Employees:
- -
Office Location:
161 Campus Drive,Level 2,Murdoch University,Murdoch,Western Australia,Australia
Zip Code:
6150
Fax:
61 8 9360 2899
Introduction:
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment degenerative tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.